Publication dates

All regions

Clinical Study Industry, October 2014 Market Research & Statistics

You might be interested in: drug, vaccine, hospital, more »

1-10 of about 3 500 reports for Clinical Study

Esperion Therapeutics Incorporated - Annual Report, 2013

  • 2013 Annual Report
  • January 2013
    116 pages
  • Equity Market  

    Preferred Stock  

    Common Stock  

  • United States  

View report >

Annual Report, 2014

  • Leonhardt Ventures 2013 Annual Report Newsletter
  • January 2014
    84 pages
  • United States  

    World  

View report >

Drug And Medication Sales Demand in China - Forecast

  • Sihuan Pharmaceutical ( Hk ) Consumer Non-cyclical - Pharmaceuti...
  • July 2013
    16 pages
  • Drug And Medica...  

    Drug  

  • China  

View report >

Analyst Report, June 2013

  • June 2013
    7 pages
  • United States  

    France  

View report >

Cigarette Industry in the US

  • Up in Smoke: Changes Sweep the Tobacco Industry
  • April 2014
    8 pages
  • Cigarette  

  • United States  

    China  

View report >

Drug And Medication Sales Demand in Japan - Forecast

  • January 2013
    8 pages
  • Drug And Medica...  

    Pathology  

    Pharmaceutical  

  • Japan  

    China  

    United States  

View report >

Athersys Incorporated - Annual Report, 2013

  • 2013 Annual Report
  • January 2013
    108 pages
  • United States  

    Turkey  

View report >

Lfb Biomedicaments Sa - Annual Report, 2013

  • Annual Report 2013
  • January 2013
    28 pages
  • France  

View report >

General Medicine And Specialty Medicine Demand Forecast Statistics in the US

  • Isoray inc
  • July 2014
    18 pages
  • General Medicin...  

    Pathology  

  • United States  

View report >

Oxford Biomedica - Investor Report, August 2014

  • 2014 Interim Results
  • August 2014
    18 pages
View report >
76 reports for Clinical Study

Purchase Reports From Reputable Market Research Publishers
(From $ 125 - $ 5 795)

OncoMed Pharmaceuticals, Inc. (OMED) - Financial and Strategic SWOT Analysis Review

OncoMed Pharmaceuticals, Inc. (OMED) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary OncoMed Pharmaceuticals, Inc. (OncoMed) is a biotechnology company. The company discovers and develops monoclonal antibody therapeutics. Its product pipeline includes demcizumab, OMP-59R5, vantictumab, ...



ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.